Ocean Biomedical, Inc. (NASDAQ:OCEAW) Sees Significant Growth in Short Interest

Ocean Biomedical, Inc. (NASDAQ:OCEAW) saw a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 49,800 shares, an increase of 80.4% from the November 15th total of 27,600 shares. Based on an average daily volume of 34,400 shares, the days-to-cover ratio is currently 1.4 days.

Ocean Biomedical Stock Down 2.0 %

Shares of NASDAQ:OCEAW traded down $0.00 during midday trading on Thursday, hitting $0.03. The company had a trading volume of 6,029 shares, compared to its average volume of 41,808. The firm has a fifty day simple moving average of $0.04 and a 200 day simple moving average of $0.04. Ocean Biomedical has a 12 month low of $0.02 and a 12 month high of $0.70.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.